UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION

Washington,
D.C. 20549



FORM
10-K/A

(Amendment
No.1)



(Mark
One)

[X]
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934



For
the fiscal year ended December 31, 2019



[  ]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934



For
the transition period from ____________ to ____________



Commission
file number: 001-36268



Akers
Biosciences, Inc.

(Exact
name of registrant as specified in its charter)



|New
    Jersey                                                                                                          |  | 22-2983783                                                                                      
|----------------------------------------------------------------------------------------------------------------------- |  | ------------------------------------------------------------------------------------------------
|(State
                                         or other jurisdiction of
        incorporation
        or organization) |  | (I.R.S.
                                         Employer
        Identification
        Number)



|201
                                         Grove Road
        Thorofare,
        NJ |  | 08086         
|------------------------------------------------------------------------------------- |  | --------------
|(Address
    of principal executive offices)                                          |  | (Zip
    Code)



Registrant’s
telephone number, including area code: (856) 848-8698



Securities
registered pursuant to Section 12(b) of the Act:



|Title
    of Each Class:                 |  | Trading
    Symbol(s) |  | Name
    of Each Exchange on Which Registered:
|---------------------------------------- |  | --------------------- |  | ----------------------------------------------
|Shares
    of common stock, no par value |  | AKER                  |  | The
    NASDAQ Stock Market LLC               



Securities
registered pursuant to Section 12(g) of the Act: None



Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [  ]
No [X]



Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes
[  ] No [X]



Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]



Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit and post such files). Yes [X] No [  ]



Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer, “smaller
reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



|Large
    accelerated filer |  | [  ] |  | Accelerated
    filer         |  | [  ]
|--------------------------- |  | ---- |  | ----------------------------- |  | ----
|Non-accelerated
    filer   |  | [X]  |  | Smaller
    reporting company |  | [X] 
|Emerging
    growth company |  | [  ] |  |                               |  |     



If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]



Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No
[X]



The
aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant on June 28, 2019, based
on a closing price of $10.80 was $5,835,000. As of March 24, 2020, the registrant had 2,700,240 shares of its common stock, no
par value per share, outstanding.



DOCUMENTS
INCORPORATED BY REFERENCE



None.






















EXPLANATORY
NOTE



This
Amendment No. 1 to the Annual Report on Form 10-K of Akers Biosciences, Inc. (the “Company”) for the
year ended December 31, 2019 as filed with the Securities and Exchange Commission on March 25, 2020 (the “Original Form
10-K”) is being filed only for the purpose of providing a composite list of the Company’s amended and restated
certificate of incorporation and the amendments thereto.



Except
as otherwise expressly noted herein, this Amendment No. 1 does not modify or update in any way the Original Form 10-K, nor does
it reflect events occurring after the filing of the Original Form 10-K. Accordingly, this Amendment No. 1 should be read in conjunction
with the Original Form 10-K.















PART
IV



Item
15. Exhibits, Financial Statement Schedules.



|(1) | Financial
    Statements
|--- | ------------------------



No
financial statements are filed with this Amendment No. 1. These items were included as part of the Original Form 10-K.



|(2) | Financial
    Statements Schedule
|--- | ---------------------------------



None.



|(3) | Exhibits
|--- | --------



|Exhibit
        Number |  | Description                                                                                                                                                                                                                                                                                                                            
|---------------------- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.1                    |  | Amended
    & Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company’s Registration
    Statement on Form S-1 filed with the Securities and Exchange Commission on August 7, 2013).                                                                                                     
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.2±                   |  | Certificate
    of Amendment to Certificate of Incorporation dated May 31, 2005.                                                                                                                                                                                                                                                       
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.3±                   |  | Certificate
    of Amendment to Certificate of Incorporation dated December 20, 2006.                                                                                                                                                                                                                                                  
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.4                    |  | Amendment
    to Certificate of Incorporation dated June 2, 2008 (incorporated herein by reference to Exhibit 3.2 to the Company’s
    Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 7, 2013).                                                                                        
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.5                    |  | Amendment
    to Certificate of Incorporation, Certificate of Designation of Series A Preferred Stock, dated September 21, 2012. (incorporated
    herein by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and
    Exchange Commission on August 7, 2013).                    
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.6                    |  | Amendment
    to Certificate of Incorporation dated January 22, 2013 (incorporated herein by reference to Exhibit 3.4 to the Company’s
    Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 7, 2013).                                                                                    
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.7                    |  | Amended
    and Restated By-laws dated August 5, 2013 (incorporated herein by reference to Exhibit 3.5 to the Company’s Registration
    Statement on Form S-1 filed with the Securities and Exchange Commission on August 7, 2013).                                                                                                   
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.8                    |  | Amendment
    to Restated By-laws dated May 11, 2016 (incorporated herein by reference to Exhibit 3.6 to the Company’s Current Report
    on Form 8-K filed with the Securities and Exchange Commission on May 18, 2016).                                                                                                              
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.9                    |  | Certificate
    of Amendment to Certificate of Incorporation, Certificate of Designation of Series B Convertible Preferred Stock, dated December
    19, 2017 (incorporated herein by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the
    Securities and Exchange Commission on December 26, 2017).
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.10                   |  | Amendment
    to Amended and Restated By-Laws, dated October 19, 2018 (incorporated herein by reference to Exhibit 3.1 to the Company’s
    Current Report on Form 8-K filed with the Securities and Exchange Commission on October 19, 2018).                                                                                         
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.11                   |  | Certificate
    of Amendment (incorporated herein by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with
    the Securities and Exchange Commission on November 9, 2018).                                                                                                                                  
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.12*                  |  | Certificate
    of Designation of Series C Convertible Preferred Stock, dated December 9, 2019.                                                                                                                                                                                                                                        
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.13±                  |  | Certificate
    of Amendment to the Certificate of Incorporation.                                                                                                                                                                                                                                                                      
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.14                   |  | Certificate
    of Amendment to Certificate of Incorporation dated November 15, 2019 (incorporated herein by reference to Exhibit 3.1 to the
    Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 29, 2019).                                                                         
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.15                   |  | Certificate of Amendment to Certificate of Incorporation dated November 22, 2019 (incorporated herein by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 29, 2019).                                                                                 
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|3.16                   |  | Certificate
    of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock (incorporated herein by reference
    to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March
    24, 2020).                                               
|                       |  |                                                                                                                                                                                                                                                                                                                                        
|4.1                    |  | Form
    of Underwriters’ Warrant (incorporated by reference to Exhibit 4.1 to the to the Company’s Registration Statement
    on Form S-1 filed with the Securities Exchange Commission on November 18, 2013).                                                                                                                        











|4.2   |  | Form
    of Warrant (incorporated herein by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the
    Securities and Exchange Commission on January 10, 2017).                                                                                                                                                                                                                                                                                                                                                 
|----- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|4.3   |  | Form
    of Purchaser Warrant (incorporated herein by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed
    with the Securities and Exchange Commission on April 5, 2017).                                                                                                                                                                                                                                                                                                                                          
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|4.4   |  | Form
    of Placement Agent Warrant (incorporated herein by reference to Exhibit 4.2 to the Company’s Current Report on Form
    8-K filed with the Securities and Exchange Commission on April 5, 2017).                                                                                                                                                                                                                                                                                                                                    
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|4.5   |  | Form
    of Purchaser Warrant (incorporated herein by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed
    with the Securities and Exchange Commission on October 13, 2017).                                                                                                                                                                                                                                                                                                                                       
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|4.6   |  | Form
    of Underwriter’s Warrant (incorporated herein by reference to Exhibit 4.1 to the Company’s Registration Statement
    on Form S-1 filed with the Securities and Exchange Commission on December 15, 2017).                                                                                                                                                                                                                                                                                                                          
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|4.7   |  | Form
    of Common Stock Purchase Warrant (incorporated herein by reference to Exhibit 4.1 to the Company’s Registration Statement
    on Form S-1 filed with the Securities and Exchange Commission on December 15, 2017).                                                                                                                                                                                                                                                                                                                  
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|4.8   |  | Form
    of Warrant (incorporated herein by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the
    Securities and Exchange Commission on October 31, 2018).                                                                                                                                                                                                                                                                                                                                                 
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|4.9   |  | Form
    of Series C Convertible Preferred Stock Warrant Certificate (incorporated herein by reference to Exhibit 4.9 to the Company’s
    Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on November 29, 2019).                                                                                                                                                                                                                                                                                     
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|4.10  |  | Form
    of Pre-Funded Warrant Certificate (incorporated herein by reference to Exhibit 4.10 to the Company’s Registration Statement
    on Form S-1/A filed with the Securities and Exchange Commission on November 29, 2019).                                                                                                                                                                                                                                                                                                              
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|4.11  |  | Form
    of Placement Agent Warrant Certificate (incorporated herein by reference to Exhibit 4.11 to the Company’s Registration
    Statement on Form S-1/A filed with the Securities and Exchange Commission on November 29, 2019).                                                                                                                                                                                                                                                                                                         
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|4.12* |  | Description
    of Securities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|10.1  |  | Amended
    License and Supply Agreement by and between Akers Biosciences, Inc. and Chubeworkx Guernsey Limited (as successor to Sono
    International Limited) (“Chubeworkx”), (EN)10 (Guernsey) Limited (formerly BreathScan International (Guernsey)
    Limited) and (EN)10 Limited (formerly BreathScan International Limited), dated June 12, 2013 (incorporated herein by reference
    to Exhibit 10.4 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission
    on August 7, 2013).
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|10.2  |  | Share
    Purchase Agreement by and between Akers Biosciences, Inc. and Chubeworkx, dated June 12, 2013. (incorporated herein by reference
    to Exhibit 10.5 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission
    on August 7, 2013).                                                                                                                                                                                                                                                 
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|10.3  |  | Subscription
    Agreement by and between Akers Biosciences, Inc. and Chubeworkx, dated June 12, 2013(incorporated herein by reference to Exhibit
    10.7 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August
    7, 2013).                                                                                                                                                                                                                                                     
|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
|10.4  |  | Subscription
    Agreement by and between Akers Biosciences, Inc. and Thomas J. Knox, dated September 14, 2012(incorporated herein by reference
    to Exhibit 10.8 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission
    on August 7, 2013).                                                                                                                                                                                                                                            













|10.5 |  | Promissory
    Note entered into by Thomas J Knox issued in favor of Akers Biosciences, Inc., dated September 14, 2012. (incorporated herein
    by reference to Exhibit 10.9 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange
    Commission on August 7, 2013).                                                                                 
|---- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|     |  |                                                                                                                                                                                                                                                                                                                                                                                             
|10.6 |  | License
    and Supply Agreement by and among the Company, Sono International Limited (“SIL”), BreathScan International (Guersney)
    Limited and BreathScan International Limited, dated June 19, 2012 (incorporated herein by reference to Exhibit 10.10 to the
    Company’s Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on October 8, 2013).
|     |  |                                                                                                                                                                                                                                                                                                                                                                                             
|10.7 |  | Distribution
    Agreement by and among the Company and Fisher Healthcare, and Amendment thereto, dated June 15, 2010 and May 1, 2012, respectively.
    (incorporated herein by reference to Exhibit 10.11 to the Company’s Registration Statement on Form S-1/A filed with
    the Securities and Exchange Commission on October 8, 2013).                                                



|10.8   |  | National
    Brand Distribution Agreement by and among the Company and Cardinal Health 2000, and Amendment thereto, dated May 1, 2007 and
    June 1, 2008, respectively. (incorporated herein by reference to Exhibit 10.12 to the Company’s Registration Statement
    on Form S-1/A filed with the Securities and Exchange Commission on October 8, 2013).
|------ |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|       |  |                                                                                                                                                                                                                                                                                                                                                              
|10.9#  |  | 2013
    Incentive Stock and Award Plan (incorporated herein by reference to Exhibit 10.14 to the Company’s Registration Statement
    on Form S-1/A filed with the Securities and Exchange Commission on December 6, 2013).                                                                                                                                 
|       |  |                                                                                                                                                                                                                                                                                                                                                              
|10.10# |  | Form
    of Nonqualified Stock Option Agreement (Non-Employee) (incorporated herein by reference to Exhibit 10.15 to the Company’s
    Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on December 6, 2013).                                                                                                          
|       |  |                                                                                                                                                                                                                                                                                                                                                              
|10.11# |  | Form
    of Nonqualified Stock Option Agreement (Employee) (incorporated herein by reference to Exhibit 10.16 to the Company’s
    Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on December 6, 2013).                                                                                                              
|       |  |                                                                                                                                                                                                                                                                                                                                                              
|10.12# |  | Form
    of Restricted Stock Agreement (incorporated herein by reference to Exhibit 10.17 to the Company’s Registration Statement
    on Form S-1/A filed with the Securities and Exchange Commission on December 6, 2013).                                                                                                                                  
|       |  |                                                                                                                                                                                                                                                                                                                                                              
|10.13# |  | Form
    of Incentive Stock Option (incorporated herein by reference to Exhibit 10.18 to the Company’s Registration Statement
    on Form S-1/A filed with the Securities and Exchange Commission on December 6, 2013).                                                                                                                                      
|       |  |                                                                                                                                                                                                                                                                                                                                                              
|10.14  |  | Letter
    Agreement, dated December 3, 2013, by and between the Company and Mr. Thomas Knox (incorporated herein by reference to Exhibit
    10.19 to the Company’s Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on December
    6, 2013).                                                                        
|       |  |                                                                                                                                                                                                                                                                                                                                                              
|10.15  |  | Joint
    Venture Agreement, dated October 24, 2014, by and between Akers Biosciences, Inc., Hainan Savy Investment Management Ltd,
    and Thomas Knox (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed
    with the Securities and Exchange Commission on October 29, 2014).                            
|       |  |                                                                                                                                                                                                                                                                                                                                                              
|10.16  |  | Amended
    and Restated 2013 Incentive Stock and Award Plan (incorporated herein by reference to Exhibit 10.1 to the Company’s
    Current Report on Form 8-K filed with the Securities and Exchange Commission on January 9, 2015).                                                                                                                        













|10.17  |  | Form
    of Lock Up Agreement (incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed
    with the Securities and Exchange Commission on January 9, 2015).                                                                                                        
|------ |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|       |  |                                                                                                                                                                                                                                                                                                               
|10.18# |  | Employment
    Agreement between the Company and John J Gormally, dated December 1, 2015. (incorporated herein by reference to Exhibit 10.1
    to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on December 3, 2015).                                           
|       |  |                                                                                                                                                                                                                                                                                                               
|10.19  |  | First
    Amendment to the Amended and Restated 2013 Incentive Stock and Award Plan (incorporated by referenced to Exhibit 10.2 to the
    Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 12, 2016).                                                       
|       |  |                                                                                                                                                                                                                                                                                                               
|10.20  |  | Form
    of Placement Agency Agreement, dated March 30, 2017, by and between Akers Biosciences, Inc. and Joseph Gunnar and Co., LLC
    (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities
    and Exchange Commission on April 5, 2017).
|       |  |                                                                                                                                                                                                                                                                                                               
|10.21  |  | Form
    of Securities Purchase Agreement, dated March 30, 2017, by and between Akers Biosciences, Inc. and various purchasers. (incorporated
    herein by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange
    Commission on April 5, 2017).    
|       |  |                                                                                                                                                                                                                                                                                                               
|10.22  |  | Form
    Registration Rights Agreement, dated March 30, 2017, by and between Akers Biosciences, Inc. and various purchasers (incorporated
    herein by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange
    Commission on April 5, 2017).        
|       |  |                                                                                                                                                                                                                                                                                                               
|10.23# |  | Akers
    Biosciences, Inc. 2017 Equity Incentive Plan (incorporated herein by reference to Exhibit 10.1 to the Company’s Current
    Report on Form 8-K filed with the Securities and Exchange Commission on August 8, 2017).                                                                                
|       |  |                                                                                                                                                                                                                                                                                                               
|10.24  |  | Form
    Warrant Exercise Agreement, dated October 12, 2017 by and between Akers Biosciences, Inc. and various holders (incorporated
    herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange
    Commission on October 13, 2017).          
|       |  |                                                                                                                                                                                                                                                                                                               
|10.25# |  | Form
    of Resignation Agreement (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K
    filed with the Securities and Exchange Commission on October 11, 2018).                                                                                                   
|       |  |                                                                                                                                                                                                                                                                                                               
|10.26# |  | Offer
    of Employment, dated October 5, 2018 (incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report
    on Form 8-K filed with the Securities and Exchange Commission on October 11, 2018).                                                                                      
|       |  |                                                                                                                                                                                                                                                                                                               
|10.27  |  | Form
    of Securities Purchase Agreement, dated October 31, 2018, by and among the Company and the investors signatory thereto (incorporated
    herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and
    Exchange Commission on October 31, 2018). 
|       |  |                                                                                                                                                                                                                                                                                                               
|10.28  |  | Akers
    Biosciences, Inc. 2018 Equity Incentive Plan (incorporated herein by reference to Exhibit 10.1 to the Company’s Current
    Report on Form 8-K filed with the Securities and Exchange Commission on December 7, 2018).                                                                              
|       |  |                                                                                                                                                                                                                                                                                                               
|10.29  |  | Form
    of Securities Purchase Agreement (incorporated herein by reference to Exhibit 10.29 to the Company’s Registration
    Statement on Form S-1/A filed with the Securities and Exchange Commission on November 29, 2019).                                                                               
|       |  |                                                                                                                                                                                                                                                                                                               
|10.30# |  | Offer
    of Employment, dated January 6, 2020 (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report
    on Form 8-K filed with the Securities and Exchange Commission on January 6, 2020).                                                                                       
|       |  |                                                                                                                                                                                                                                                                                                               
|10.31# |  | Offer
    of Employment, dated January 31, 2020 (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report
    on Form 8-K filed with the Securities and Exchange Commission on January 31, 2020).                                                                                     













|10.32  |  | Membership
    Interest Purchase Agreement ((incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form
    8-K filed with the Securities and Exchange Commission on March 24, 2020).
|------ |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|       |  |                                                                                                                                                                                                                    
|10.33  |  | Support
    Agreement (incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the
    Securities and Exchange Commission on March 24, 2020).                      
|       |  |                                                                                                                                                                                                                    
|10.34  |  | Registration
    Rights Agreement (incorporated herein by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed
    with the Securities and Exchange Commission on March 24, 2020).          
|       |  |                                                                                                                                                                                                                    
|10.35  |  | License
    Agreement (incorporated herein by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the
    Securities and Exchange Commission on March 24, 2020).                      
|       |  |                                                                                                                                                                                                                    
|21.1*  |  | List
    of Subsidiaries.                                                                                                                                                                                          
|       |  |                                                                                                                                                                                                                    
|23.1*  |  | Consent
    of Morison Cogen LLP, Independent Registered Public Accounting Firm.                                                                                                                                   
|       |  |                                                                                                                                                                                                                    
|31.1±  |  | Certification
    of the Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).                                                                                                                 
|       |  |                                                                                                                                                                                                                    
|31.2±  |  | Certification
    of the Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).                                                                                                                 
|       |  |                                                                                                                                                                                                                    
|32.1** |  | Certification of the Principal Executive Officer and Principal Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350                                                                   



|* | Previously
    filed with the Original Form 10-K.
|- | -------------------------------------------------



|** | Furnished
                                         with the Original Form 10-K.
|-- | -------------------------------------------------------------------------------
|   |                                                                                
|±  | Filed
    herewith.                                                            
|   |                                                                                
|#  | Management
    contract or compensatory plan or arrangement.                   















SIGNATURES



Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf
of the Registrant.



|                           | AKERS
    BIOSCIENCES, INC.
|-------------------------- | ---------------------------
|                           |                            
|Date:
    October 21, 2020 | By:                        
|                           | Name:                      
|                           | Title:                     
|                           |